Statement on smoking cessation in COPD and other pulmonary diseases and in smokers with comorbidities who find it difficult to quit
Year: 2015
Type: article
Abstract: Chronic obstructive pulmonary disease (COPD), lung cancer, asthma and pulmonary tuberculosis are common pulmonary diseases that are caused or worsened by tobacco smoking. Growing observational evidence suggests that symptoms and prognosis of these conditions improve upon smoking cessation. Despite increasing numbers of (small) randomised controlled trials suggesting intensive smoking cessation treatments work in people with pulmonary diseases many patients are not given specific advice on the benefits or referred for intensive cessation treatments and, therefore, continue smoking.This is a qualitative review regarding smoking cessation in patients with COPD and other pulmonary disorders, written by a group of European Respiratory Society experts. We describe the epidemiological links between smoking and pulmonary disorders, the evidence for benefits of stopping smoking, how best to assess tobacco dependence and what interventions currently work best to help pulmonary patients quit. Finally, we describe characteristics and management of any "hardcore" smoker who finds it difficult to quit with standard approaches.
Source: European Respiratory Journal
Institutions: Comunidad de Madrid, Universitätsmedizin Göttingen, Swansea University, Glostrup Hospital, Maastricht University, Care and Public Health Research Institute, Queen Mary University of London, Oslo University Hospital, Pitié-Salpêtrière Hospital, European Lung Foundation, Ospedale Civile di Vittorio Veneto, University of Bern, Institute of Social and Preventive Medicine, National and Kapodistrian University of Athens
Language: English
Subfield: Physiology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W2156989336